Prognostic Value of Texture Analysis Based on Pretreatment DWI-Weighted MRI for Esophageal Squamous Cell Carcinoma Patients Treated With Concurrent Chemo-Radiotherapy

被引:9
|
作者
Li, Zhenjiang [1 ]
Han, Chun [2 ]
Wang, Lan [2 ]
Zhu, Jian [1 ]
Yin, Yong [1 ]
Li, Baosheng [1 ]
机构
[1] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Jinan, Shandong, Peoples R China
[2] Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2019年 / 9卷
基金
中国国家自然科学基金;
关键词
esophageal squamous cell cancer; texture analysis; magnetic resonance imaging; diffusion-weighted magnetic resonance imaging; chemo-radiotherapy; TUMOR HETEROGENEITY; RECTAL-CARCINOMA; REPRODUCIBILITY; CHEMORADIATION; FEATURES; STAGE;
D O I
10.3389/fonc.2019.01057
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The purpose of the research was to assess the prognostic value of three-dimensional (3D) texture features based on diffusion-weighted magnetic resonance imaging (DWI) for esophageal squamous cell carcinoma (ESCC) patients undergoing concurrent chemo-radiotherapy (CRT). Methods: We prospectively enrolled 82 patients with ESCC into a cohort study. Two DWI sequences (b = 0 and b = 600 s/mm(2)) were acquired along with axial T2WI and T1WI before CRT. Two groups of features were examined: (1) clinical and demographic features (e.g., TNM stage, age and sex) and (2) changes in spatial texture characteristics of the apparent diffusion coefficient (ADC), which characterizes gray intensity changes in tumor areas, spatial pattern and distribution, and related changes caused by CRT. Reproducible feature sets without redundancy were statistically filtered and validated. The prognostic values associated with overall survival (OS) for each parameter were studied using Kaplan-Meier and Cox regression models for univariate and multivariate analyses, respectively. Results: Both univariate and multivariate Cox model analyses showed that the energy of intensity histogram texture (IHIST_energy), radiation dose, mean of the contrast in distance 1 of 26 directions (m_contrast_1), extreme difference of the homogeneity in distance 2 of 26 directions (Diff_homogeneity_2), mean of the inverse variance in distance 2 of 26 directions (m_lnversevariance_2), high-intensity small zone emphasis (HISE), and low-intensity large zone emphasis (LILE) were significantly associated with survival. The results showed that 6 texture parameters extracted from the ADC images before treatment could distinguish among high-, medium-, and low-risk groups (log-rank chi(2) = 9.7; P = 0.00773). The biased C-index value was 0.715 (95% CI: 0.708 to 0.732) based on bootstrapping validation. Conclusions: The ADC 3D texture feature can be used as a useful biomarker to predict the survival of ESCC patients undergoing CRT. Combining ADC 3D texture features with conventional prognostic factors can generate reliable survival prediction models.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] What is the prognostic impact of FDG PET in locally advanced head and neck squamous cell carcinoma treated with concomitant chemo-radiotherapy? A systematic review and meta-analysis
    Pierluigi Bonomo
    A. Merlotti
    E. Olmetto
    A. Bianchi
    I. Desideri
    A. Bacigalupo
    P. Franco
    C. Franzese
    E. Orlandi
    L. Livi
    S. Caini
    European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 2122 - 2138
  • [32] What is the prognostic impact of FDG PET in locally advanced head and neck squamous cell carcinoma treated with concomitant chemo-radiotherapy? A systematic review and meta-analysis
    Bonomo, Pierluigi
    Merlotti, A.
    Olmetto, E.
    Bianchi, A.
    Desideri, I.
    Bacigalupo, A.
    Franco, P.
    Franzese, C.
    Orlandi, E.
    Livi, L.
    Caini, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (12) : 2122 - 2138
  • [33] Mutation Profile Prognostic Value in Stage III Non Small Cell Lung Cancer (NSCLC) Patients Treated with Chemo-Radiotherapy (CRT)
    Boros, Angela
    Lacroix, Ludovic
    Lancas, Benjamin
    Adam, Julien
    Pignon, Jean-Pierre
    Caramella, Caroline
    Planchard, David
    Levy, Antonin
    De Montpreville, Vincent
    Deutsch, Eric
    Besse, Benjamin
    Le Pechoux, Cecile
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S288 - S288
  • [34] Longitudinal Dynamic Trajectories of Inflammatory Biomarkers as Prognostic Factors for Esophageal Squamous Cell Carcinoma Patients Receiving Definitive (Chemo) Radiotherapy
    Li, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E462 - E463
  • [35] The Prognostic Significance of Nomogram-Based Pretreatment Inflammatory Indicators in Patients With Esophageal Squamous Cell Carcinoma Receiving Intensity-Modulated Radiotherapy
    Xu, Zhiyang
    Ke, Hongqian
    Zheng, Binglin
    Lin, Chuyan
    Zhang, Yiping
    Wang, Liyan
    Lin, Yu
    Ye, Yuling
    Cai, Lifang
    You, Mengxing
    Chen, Junqiang
    Xu, Yuanji
    CANCER CONTROL, 2023, 30
  • [36] Prognostic impact of eosinophils in peripheral blood and tumor site in patients with esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy
    Yang, Xiyue
    Wang, Lei
    Du, Huan
    Lin, Binwei
    Yi, Jie
    Wen, Xuemei
    Geng, Lidan
    Du, Xiaobo
    MEDICINE, 2021, 100 (03) : E24328
  • [37] Endoscopic Traversability in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma Treated With Concurrent Chemoradiotherapy: Is it an Important Prognostic Factor?
    Moon, Hee Seok
    Jeong, Hyun Yong
    Sung, Jaekyu
    GASTROINTESTINAL ENDOSCOPY, 2017, 85 (05) : AB212 - AB212
  • [38] Endoscopic traversability in patients with locally advanced esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy: Is it an important prognostic factor?
    Hyung, Kang Sun
    Kyu, Sung Jae
    Yong, Jeong Hyun
    Seok, Moon Hee
    ANNALS OF ONCOLOGY, 2017, 28
  • [39] An Open Label, Multicenter Clinical Study of Cetuximab Combined with Concurrent Chemo-radiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: Preliminary Results of a Phase II Trial
    Yu, J.
    Wang, J. H.
    Sun, X. D.
    Wang, L. H.
    Zhu, G. Y.
    Feng, P. B.
    Ye, M.
    Lu, Y.
    Zhu, S. C.
    Liao, Z. X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S309 - S309
  • [40] Nimotuzumab combined with concurrent chemo-radiotherapy in patients with locally advanced cervical squamous cell carcinoma: A randomized, controlled, open-label, multicenter study
    Wang, J.
    Jiang, P.
    Wei, L.
    Zou, L.
    Li, X.
    Wang, C.
    Sun, X.
    Ding, L.
    Yuan, X.
    Cheng, H.
    Wu, D.
    Cai, R.
    Yin, R.
    Zhang, J.
    Qiu, H.
    Wang, T.
    Gao, K.
    Zhuo, Y.
    Zhang, Y.
    Zhao, F.
    ANNALS OF ONCOLOGY, 2023, 34 : S518 - S519